History of Early Childhood Infections and Acute Lymphoblastic Leukemia Risk Among Children in a US Integrated Health-Care System.
childhood ALL
childhood leukemia
early-life infections
medical record
Journal
American journal of epidemiology
ISSN: 1476-6256
Titre abrégé: Am J Epidemiol
Pays: United States
ID NLM: 7910653
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
received:
12
11
2019
revised:
20
12
2019
accepted:
14
04
2020
pubmed:
24
4
2020
medline:
27
11
2020
entrez:
24
4
2020
Statut:
ppublish
Résumé
Surrogate measures of infectious exposures have been consistently associated with lower childhood acute lymphoblastic leukemia (ALL) risk. However, recent reports have suggested that physician-diagnosed early-life infections increase ALL risk, thereby raising the possibility that stronger responses to infections might promote risk. We examined whether medically diagnosed infections were related to childhood ALL risk in an integrated health-care system in the United States. Cases of ALL (n = 435) diagnosed between 1994-2014 among children aged 0-14 years, along with matched controls (n = 2,170), were identified at Kaiser Permanente Northern California. Conditional logistic regression was used to estimate risk of ALL associated with history of infections during first year of life and across the lifetime (up to diagnosis). History of infection during first year of life was not associated with ALL risk (odds ratio (OR) = 0.85, 95% confidence interval (CI): 0.60, 1.21). However, infections with at least 1 medication prescribed (i.e., more "severe" infections) were inversely associated with risk (OR = 0.42, 95% CI: 0.20, 0.88). Similar associations were observed when the exposure window was expanded to include medication-prescribed infections throughout the subjects' lifetime (OR = 0.52, 95% CI: 0.32, 0.85).
Identifiants
pubmed: 32322901
pii: 5823933
doi: 10.1093/aje/kwaa062
pmc: PMC7670873
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
1076-1085Subventions
Organisme : NCI NIH HHS
ID : R01 CA185058
Pays : United States
Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
Pediatr Blood Cancer. 2015 Jul;62(7):1155-61
pubmed: 25790083
Am Econ Rev. 2008 Dec;98(5):2242-2258
pubmed: 19079738
EGEMS (Wash DC). 2014 Mar 24;2(1):1049
pubmed: 25848584
Cancer. 1996 Aug 1;78(3):532-41
pubmed: 8697401
Int J Cancer. 2017 Mar 1;140(5):1000-1008
pubmed: 27778348
Lancet. 1988 Dec 10;2(8624):1323-7
pubmed: 2904050
Cancer Causes Control. 2012 Sep;23(9):1587-91
pubmed: 22798182
Radiat Prot Dosimetry. 2008;132(2):259-66
pubmed: 18940822
Cancer Res. 2018 Sep 15;78(18):5458-5463
pubmed: 30217873
Int J Epidemiol. 2012 Aug;41(4):1050-9
pubmed: 22836110
Br J Cancer. 1999 Jul;80(9):1483-9
pubmed: 10424755
Br J Cancer. 2018 Jan;118(1):127-137
pubmed: 29065105
Am J Epidemiol. 2015 Apr 15;181(8):549-62
pubmed: 25731888
Ann Epidemiol. 2000 Oct 1;10(7):474
pubmed: 11018411
Nat Rev Cancer. 2006 Mar;6(3):193-203
pubmed: 16467884
Br J Cancer. 2008 Nov 4;99(9):1529-33
pubmed: 18827817
Haematologica. 2019 Nov;104(11):e514-e516
pubmed: 30923090
J Natl Cancer Inst. 1997 Jul 2;89(13):939-47
pubmed: 9214673
Pediatr Blood Cancer. 2013 Mar;60(3):428-32
pubmed: 22915267
Lancet. 1997 Feb 1;349(9048):344-9
pubmed: 9024390
Am J Epidemiol. 2007 Mar 1;165(5):496-504
pubmed: 17182983
Br J Cancer. 1999 Aug;80(11):1844-51
pubmed: 10468308
Br J Cancer. 2015 Mar 17;112(6):1017-26
pubmed: 25675150
Int J Epidemiol. 2001 Dec;30(6):1428-37
pubmed: 11821358
Cancer Epidemiol Biomarkers Prev. 2011 Aug;20(8):1736-40
pubmed: 21653647
Int J Epidemiol. 2010 Jun;39(3):718-32
pubmed: 20110276
Am J Epidemiol. 2012 Sep 1;176(5):402-8
pubmed: 22899827
Int J Epidemiol. 2005 Oct;34(5):1100-9
pubmed: 15951359